BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38494680)

  • 21. ADP-ribosylation factor-like GTPase 15 enhances insulin-induced AKT phosphorylation in the IR/IRS1/AKT pathway by interacting with ASAP2 and regulating PDPK1 activity.
    Zhao J; Wang M; Deng W; Zhong D; Jiang Y; Liao Y; Chen B; Zhang X
    Biochem Biophys Res Commun; 2017 May; 486(4):865-871. PubMed ID: 28322786
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ADP-dependent glucokinase controls metabolic fitness in prostate cancer progression.
    Xu H; Li YF; Yi XY; Zheng XN; Yang Y; Wang Y; Liao DZ; Zhang JP; Tan P; Xiong XY; Jin X; Gong LN; Qiu S; Cao DH; Li H; Wei Q; Yang L; Ai JZ
    Mil Med Res; 2023 Dec; 10(1):64. PubMed ID: 38082365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LncRNA CAR10 Upregulates PDPK1 to Promote Cervical Cancer Development by Sponging miR-125b-5p.
    Hu T; Zhang Q; Gao L
    Biomed Res Int; 2020; 2020():4351671. PubMed ID: 32025520
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated expression and potential roles of human Sp5, a member of Sp transcription factor family, in human cancers.
    Chen Y; Guo Y; Ge X; Itoh H; Watanabe A; Fujiwara T; Kodama T; Aburatani H
    Biochem Biophys Res Commun; 2006 Feb; 340(3):758-66. PubMed ID: 16380080
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LncRNA RHPN1-AS1 inhibition induces autophagy and apoptosis in prostate cancer cells via the miR-7-5p/EGFR/PI3K/AKT/mTOR signaling pathway.
    Ma X; Ren H; Zhang Y; Wang B; Ma H
    Environ Toxicol; 2022 Dec; 37(12):3013-3027. PubMed ID: 36125241
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Muscleblind-like 1 antisense RNA 1 inhibits cell proliferation, invasion, and migration of prostate cancer by sponging miR-181a-5p and regulating PTEN/PI3K/AKT/mTOR signaling.
    Ding X; Xu X; He XF; Yuan Y; Chen C; Shen XY; Su S; Chen Z; Xu ST; Huang YH
    Bioengineered; 2021 Dec; 12(1):803-814. PubMed ID: 33648424
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circular RNA midline-1 (circMID1) promotes proliferation, migration, invasion and glycolysis in prostate cancer.
    Ding Y; Wang M; Yang J
    Bioengineered; 2022 Mar; 13(3):6293-6308. PubMed ID: 35212614
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
    Zaia A; Fraizer GC; Piantanelli L; Saunders GF
    Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IMP3 accelerates the progression of prostate cancer through inhibiting PTEN expression in a SMURF1-dependent way.
    Zhang X; Wang D; Liu B; Jin X; Wang X; Pan J; Tu W; Shao Y
    J Exp Clin Cancer Res; 2020 Sep; 39(1):190. PubMed ID: 32938489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel androgen-reduced prostate-specific lncRNA, PSLNR, inhibits prostate-cancer progression in part by regulating the p53-dependent pathway.
    Wang D; Wan X; Zhang Y; Kong Z; Lu Y; Sun X; Huang Y; Ji C; Li D; Luo J; Gu W; Wang C; Li Y; Xu Y
    Prostate; 2019 Sep; 79(12):1362-1377. PubMed ID: 31269242
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TNFAIP8 drives metabolic reprogramming to promote prostate cancer cell proliferation.
    Niture S; Lin M; Odera JO; Moore J; Zhe H; Chen X; Suy S; Collins SP; Kumar D
    Int J Biochem Cell Biol; 2021 Jan; 130():105885. PubMed ID: 33227392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Triple targeting of RSK, AKT, and S6K as pivotal downstream effectors of PDPK1 by TAS0612 in B-cell lymphomas.
    Katsuragawa-Taminishi Y; Mizutani S; Kawaji-Kanayama Y; Onishi A; Okamoto H; Isa R; Mizuhara K; Muramatsu A; Fujino T; Tsukamoto T; Shimura Y; Taniwaki M; Miyagawa-Hayashino A; Konishi E; Kuroda J
    Cancer Sci; 2023 Dec; 114(12):4691-4705. PubMed ID: 37840379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Downregulation of lncRNA ZEB1-AS1 Represses Cell Proliferation, Migration, and Invasion Through Mediating PI3K/AKT/mTOR Signaling by miR-342-3p/CUL4B Axis in Prostate Cancer.
    Ma T; Chen H; Wang P; Yang N; Bao J
    Cancer Biother Radiopharm; 2020 Nov; 35(9):661-672. PubMed ID: 32275162
    [No Abstract]   [Full Text] [Related]  

  • 34. Wnt-mediated down-regulation of Sp1 target genes by a transcriptional repressor Sp5.
    Fujimura N; Vacik T; Machon O; Vlcek C; Scalabrin S; Speth M; Diep D; Krauss S; Kozmik Z
    J Biol Chem; 2007 Jan; 282(2):1225-37. PubMed ID: 17090534
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lgr4 promotes prostate tumorigenesis through the Jmjd2a/AR signaling pathway.
    Zhang J; Li Q; Zhang S; Xu Q; Wang T
    Exp Cell Res; 2016 Nov; 349(1):77-84. PubMed ID: 27743893
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progesterone Receptor Expression in the Benign Prostatic Hyperplasia and Prostate Cancer Tissues, Relation with Transcription, Growth Factors, Hormone Reception and Components of the AKT/mTOR Signaling Pathway.
    Spirina LV; Kovaleva IV; Usynin EA; Goorbunov AK; Kondakova IV
    Asian Pac J Cancer Prev; 2020 Feb; 21(2):423-429. PubMed ID: 32102520
    [TBL] [Abstract][Full Text] [Related]  

  • 37. KAT2A succinyltransferase activity-mediated 14-3-3ζ upregulation promotes β-catenin stabilization-dependent glycolysis and proliferation of pancreatic carcinoma cells.
    Tong Y; Guo D; Yan D; Ma C; Shao F; Wang Y; Luo S; Lin L; Tao J; Jiang Y; Lu Z; Xing D
    Cancer Lett; 2020 Jan; 469():1-10. PubMed ID: 31610265
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epigenetic repression of miR-375 is the dominant mechanism for constitutive activation of the PDPK1/RPS6KA3 signalling axis in multiple myeloma.
    Tatekawa S; Chinen Y; Ri M; Narita T; Shimura Y; Matsumura-Kimoto Y; Tsukamoto T; Kobayashi T; Kawata E; Uoshima N; Taki T; Taniwaki M; Handa H; Iida S; Kuroda J
    Br J Haematol; 2017 Aug; 178(4):534-546. PubMed ID: 28439875
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GLUT1 regulates cell glycolysis and proliferation in prostate cancer.
    Xiao H; Wang J; Yan W; Cui Y; Chen Z; Gao X; Wen X; Chen J
    Prostate; 2018 Feb; 78(2):86-94. PubMed ID: 29105798
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The inhibition of Akt-Pdpk1 interaction efficiently suppresses the growth of murine primary liver tumor cells.
    Mäemets-Allas K; Belitškin D; Jaks V
    Biochem Biophys Res Commun; 2016 May; 474(1):118-125. PubMed ID: 27103434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.